End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34,444 ARS | +0.45% | +2.76% | +32.05% |
05-15 | Argus Raises Price Target on Colgate-Palmolive to $107 From $97 | MT |
05-15 | Earnings Flash (CL) CRESCO LABS Posts Q1 Revenue $184.3M | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The firm trades with high earnings multiples: 26.93 times its 2024 earnings per share.
- With an enterprise value anticipated at 4.2 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+32.05% | 77.56B | - | ||
+13.63% | 393B | C- | ||
+13.16% | 142B | B- | ||
-12.83% | 65.38B | A- | ||
-7.01% | 48.76B | B+ | ||
-4.60% | 43.08B | - | ||
+6.41% | 35.13B | B- | ||
+10.36% | 18.14B | A- | ||
+14.18% | 15.83B | B | ||
-2.04% | 11.59B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CL Stock
- CL Stock
- Ratings Colgate-Palmolive Company